Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib and Topotecan in Relapsed Ovarian Cancer
NCT01690598Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Nov 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in ovarian cancer, sponsored by Vejle Hospital. Started Nov 2012; status: completed.
02
Drugs
veliparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01690598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690598.